MASH
Clinical trials for MASH explained in plain language.
Never miss a new study
Get alerted when new MASH trials appear
Sign up with your email to follow new studies for MASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut implant shows promise for diabetes and obesity control
Disease control Not yet recruitingThis study tests a new device called the Trans-Duodenal Barrier, a temporary implant placed in the upper small intestine for 6 months. It aims to lower blood sugar (HbA1c) and help with weight loss in adults with type 2 diabetes and obesity. Researchers will also check if it impr…
Matched conditions: MASH
Phase: NA • Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New MASH drug OPK-88006 enters early safety testing
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug called OPK-88006 in 30 people—first in healthy volunteers, then in those with MASH (a liver condition). The goal is to see if the drug is safe, how the body processes it, and whether it affects weight, liver fat, and other health markers. N…
Matched conditions: MASH
Phase: PHASE1, PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC